MannKind | Capitale Sociale E Riserve

Equity Capital And Reserves Cambiamento Data
Adma Biologics USD 135.21M 16.23M 2023-12
Dynavax Technologies USD 622.07M 17.16M 2023-12
Eli Lilly USD 11.22B 156.6M 2023-09
Halozyme Therapeutics USD 83.81M 165.37M 2023-12
Insmed USD -331923000 42.57M 2023-12
MannKind USD -246168000 5.61M 2023-12
Novo Nordisk DKK 92.99B 2.52B 2023-09
Pfizer USD 96.93B 2.08B 2023-09
Xencor USD 668.8M 214K 2023-12



MannKind Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.